Next-generation treatment of brain diseases – accelerating drug development

Purpose and goal

The project aims to advance one of the company’s preclinical programs to a mature lead molecule with confirmed preclinical efficacy and good brain distribution. The objective is to initiate the next phase of the preclinical development and strengthen opportunities for financing and partnerships.

Expected effects and result

The project is expected to deliver an optimized lead molecule with verified biological effect and brain exposure, and to initiate production of material in preparation for further studies. The results will be important to attract external financing and new partnerships, thereby strengthening the company’s commercial position. In the long term, the project will contribute to the development of new treatments for brain disorders and support sustainable growth of the company.

Planned approach and implementation

The project will be carried out through activities within protein engineering, preclinical distribution and efficacy studies, as well as preparations for tech transfer and production. The work includes both internal development efforts and with external collaborations. The organization will be strengthened during the project, and in parallel business development activities will be pursued to secure continued financing and partnerships.